Physician profile
Derek Phelps
NPI 1316508708
$960.43
in general payments reported to CMS, 2019-2025
12 companies · $586 in 2025
The $586 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $51.95 · 2023: $22.27 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $237.73 | 2025 | Photrexa Viscous and Photrexa |
| Regeneron Healthcare Solutions, INC. | $172.17 | 2019-2020 | |
| Spark Therapeutics, INC. | $100.30 | 2019 | |
| Alcon Vision LLC | $97.96 | 2025 | Tryptyr, Clareon Panoptix Pro |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $79.65 | 2019 | |
| Bausch & Lomb Americas INC. | $58.53 | 2025 | Xiidra, Miebo, Scoutpro Osmolarity System |
| Rayner Intraocular Lenses Limited | $55.82 | 2025 | Rayone Spheric, Rayner Cataract Set 1, Rayone Aspheric |
| Mallinckrodt Hospital Products INC. | $54.95 | 2025 | Acthar |
| Dompe US, INC. | $48.73 | 2025 | Oxervate |
| Rxsight INC | $22.27 | 2023 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Harrow Eye, LLC | $21.16 | 2025 | Iheezo |
| Lensar, INC. | $11.16 | 2025 | Lensar Laser System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Phelps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.